Alternative [cnce]
Hormone replacement therapy [topp]
lowering [spco]
Serum lipids NOS [lbpr]
Oxidative Stress [comd]
Marker [clna]
randomized [resa]
Controlled [ftcn]
Clinical Trial [resa]
Menopause [phsf]
Pro [aapp, bacs]
Atherogenesis [patf]
State [geoa]
Sharp [fndg]
coronary artery disease [dsyn]
Pilot Study [resa]
Design [acty]
Equivalent [qlco]
Randomized Clinical Trial [inpr, resa]
Containing [ftcn]
mU/g [qnco]
lycopene [bacs, orch, phsu]
Alternative [cnce]
Hormone replacement therapy [topp]
Prevention [topp]
coronary artery disease [dsyn]
postmenopausal [tmco]
Women [popg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
N NOS [aapp, imft]
N NOS [aapp, imft]
Six [qnco]
months [tmco]
serum lipid [lbpr]
Profile [lbpr]
Marker [clna]
Lipid Peroxidation [moft]
Malondialdehyde [orch]
Endogenous [ftcn]
Antioxidant [phsu]
Glutathione [aapp, bacs]
Measured [qlco]
baseline [bodm]
months [tmco]
intervention [hlca]
Group [idcn]
months [tmco]
Hormone replacement therapy [topp]
Decrease [qlco]
Total Cholesterol [lbpr]
Low-Density Lipoproteins [aapp, bacs, lipd]
High Density Lipoproteins [aapp, bacs, lipd]
Group [idcn]
Total Cholesterol [lbpr]
High Density Lipoproteins [aapp, bacs, lipd]
Triglyceride level [lbtr]
Smaller [qlco]
months [tmco]
3 Months [tmco]
Group [idcn]
Very [qlco]
Group [idcn]
Malondialdehyde [orch]
Decreased [qnco]
Glutathione [aapp, bacs]
Increased [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Hormone replacement therapy [topp]
Favorable [qlco]
Serum lipids NOS [lbpr]
Oxidative Stress [comd]
Marker [clna]
Alternative [cnce]
Hormone replacement therapy [topp]
Atherosclerosis [dsyn]
postmenopausal [tmco]
Women [popg]
